VCSH vs VHT
Vanguard Short-Term Corporate Bond ETF vs Vanguard Health Care ETF
VCSH$79.03
Vanguard Short-Term Corporate Bond ETF
Short-term investment-grade corporate bonds.
Expense: 0.03%Yield: 4.42%
VHT$271.09
Vanguard Health Care ETF
US health care sector stocks.
Expense: 0.09%Yield: 1.72%
Quick take
- • VCSH has the lower expense ratio at 0.03% vs 0.09% for VHT.
- • VCSH pays a higher dividend yield (4.42%).
Side-by-side metrics
| Metric | VCSH | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.09% |
Dividend yield Trailing 12-month yield. | 4.42% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $49.18B | $18.51B |
YTD return | 0.67% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.42 | 0.64 |
P/E ratio | — | 25.44 |
Last price | $79.03 | $271.09 |
Inception | — | — |
Issuer | Vanguard | Vanguard |
VCSH top holdings
Holdings data unavailable for VCSH.
VHT top holdings
Top holdings · VHT
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
Sector breakdown · VHT
Technology0.0%
Financial Services0.0%
Industrials0.0%
Healthcare100.0%
About VCSH
VCSH (Vanguard Short-Term Corporate Bond ETF) is Short-term investment-grade corporate bonds. Managed by Vanguard, the fund carries $49.2B in assets under management, an expense ratio of 0.03%, a dividend yield of 4.42%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.